PT  - JOURNAL ARTICLE
AU  - Farthing, Trevor S.
AU  - Lanzas, Cristina
TI  - Assessing the efficacy of interventions to control indoor SARS-Cov-2 transmission: an agent-based modeling approach
AID  - 10.1101/2021.01.21.21250240
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.21.21250240
4099  - http://medrxiv.org/content/early/2021/01/22/2021.01.21.21250240.short
4100  - http://medrxiv.org/content/early/2021/01/22/2021.01.21.21250240.full
AB  - Intervention strategies for minimizing indoor SARS-CoV-2 transmission are often based on anecdotal evidence because there is little evidence-based research to support them. We developed a spatially-explicit agent-based model for simulating indoor respiratory pathogen transmission, and used it to compare effects of four interventions on reducing individual-level SARS-CoV-2 transmission risk by simulating a well-known case study. We found that imposing movement restrictions and efficacious mask usage appear to have the greatest effects on reducing infection risk, but multiple concurrent interventions are required to minimize the proportion of susceptible individuals infected. Social distancing had little effect on reducing transmission if individuals move during the gathering. Furthermore, our results suggest that there is potential for ventilation airflow to expose susceptible people to aerosolized pathogens even if they are relatively far from infectious individuals. Maximizing rates of aerosol removal is the key to successful transmission-risk reduction when using ventilation systems as intervention tools.Article Summary Line Imposing mask usage requirements, group size restrictions, duration limits, and social distancing policies can have additive, and in some cases multiplicative protective effects on SARS-CoV-2 infection risk during indoor events.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially supported by CDC U01CK000587-01M001 and R35GM134934.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe model referred to in our manuscript is available for download at https://github.com/lanzaslab/droplet-ABM. https://github.com/lanzaslab/droplet-ABM